☰
Skip to content
Home
Studies
BioFINDER One
BioFINDER Two
BioFINDER Sleep
BioFINDER Preclinical AD
BioFINDER Primary Care
BioFINDER Memory Clinic
Study Group
Publications
News
Deltagare / Participants
Shared and disease-specific pathways in frontotemporal dementia and Alzheimer’s and Parkinson’s diseases.
2025
Nat Med. 2025 Aug;31(8):2567-2577. doi: 10.1038/s41591-025-03833-1. Epub 2025 Jul 15. PMID: 40665052 Free PMC article.
Ali M, Erabadda B, Chen Y, Xu Y, Gong K, Liu M, Pichet Binette A, Timsina J, Western D, Yang C, Heo G, Vogel JW, Tijms BM, Krish V, Imam F; Global Neurodegeneration Proteomics Consortium (GNPC); Hansson O, Winchester L, Cruchaga C.
Nat Med. 2025 Aug;31(8):2567-2577. doi: 10.1038/s41591-025-03833-1. Epub 2025 Jul 15. PMID: 40665052 Free PMC article.
2026
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology
2026
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau – a prospective cohort study
2026
A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer’s disease
2025
STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease
2025
Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group
2025
Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies
2025
Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloid
2025
Locus coeruleus-entorhinal cortex tract integrity is linked to plasma tau and glial fibrillary acidic protein
2025
Assessment of myocardial sympathetic innervation with [123I]mIBG myocardial scintigraphy: A comparative study between an Anger and a ring-configured cadmium-zinc-telluride gamma camera.
2025
Characterizing the onset and progression of Alzheimer’s pathologies using amyloid and tau PET imaging and plasma p-tau217
2025
Taurine Intake, Plasma Taurine Concentration, and Dementia Risk: Findings From the Malmö Diet and Cancer Study
2025
CSF pTDP-43 across the Alzheimer’s spectrum: Links to amyloid, APOE and vasculopathy
2025
The tau biomarker cascade is condensed in Down syndrome compared to sporadic Alzheimer’s disease
2025
Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?
2025
Estimating the time course of biomarker changes in Alzheimer’s disease